Brief: Spago Nanomedical Jan-March Net Loss Widens To SEK 5.1 Mln
April 23 (Reuters) - Spago Nanomedical AB (publ) SPAGO.TE :
* SPAGO NANOMEDICAL DELÅRSRAPPORT JANUARI-MARS 2020
* JAN-MAR NET LOSS SEK 5.1 MILLION VERSUS LOSS SEK 4.6
MILLION
YEAR AGO
Source text for Eikon: ID:nWkrbZrdVW
Further company coverage: SPAGO.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose